Author:
Bukkuri Anuraag,Pienta Kenneth J.,Austin Robert H.,Hammarlund Emma U.,Amend Sarah R.,Brown Joel S.
Abstract
AbstractRecent evidence suggests that a polyaneuploid cancer cell (PACC) state may play a key role in the adaptation of cancer cells to stressful environments and in promoting therapeutic resistance. The PACC state allows cancer cells to pause cell division and to avoid DNA damage and programmed cell death. Transition to the PACC state may also lead to an increase in the cancer cell’s ability to generate heritable variation (evolvability). One way this can occur is through evolutionary triage. Under this framework, cells gradually gain resistance by scaling hills on a fitness landscape through a process of mutation and selection. Another way this can happen is through self-genetic modification whereby cells in the PACC state find a viable solution to the stressor and then undergo depolyploidization, passing it on to their heritably resistant progeny. Here, we develop a stochastic model to simulate both of these evolutionary frameworks. We examine the impact of treatment dosage and extent of self-genetic modification on eco-evolutionary dynamics of cancer cells with aneuploid and PACC states. We find that under low doses of therapy, evolutionary triage performs better whereas under high doses of therapy, self-genetic modification is favored. This study generates predictions for teasing apart these biological hypotheses, examines the implications of each in the context of cancer, and provides a modeling framework to compare Mendelian and non-traditional forms of inheritance.
Funder
National Science Foundation
Stiftelsen Längmanska Kulturfonden
Royal Swedish Academy of Sciences Stiftelsen GS Magnusons fond
Crafoordska Stiftelsen
Prostate Cancer Foundation
National Cancer Institute
National Cancer Research Institute
US National Science Foundation
Princeton Catalysis Initiative
ParadOX-ERC Starting Grant
Swedish Research Council
US Department of Defense
Patrick C. Walsh Prostate Cancer Research Fund
Publisher
Springer Science and Business Media LLC
Reference86 articles.
1. Pienta, K. J., Hammarlund, E. U., Austin, R. H., Axelrod, R., Brown, J. S. & Amend, S. R. Cancer cells employ an evolutionarily conserved polyploidization program to resist therapy. In Seminars in Cancer Biology, 1–15 (2020).
2. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2020. CA A Cancer J. Clin. 70(1), 7–30 (2020).
3. Duesberg, P. & Rasnick, D. Aneuploidy, the somatic mutation that makes cancer a species of its own. Cell Motil. Cytoskelet. 47(2), 81–107 (2000).
4. Hanahan, D. & Weinberg, R. A. Leading edge review hallmarks of cancer: The next generation. Cell 144, 646–674 (2011).
5. Amend, S. R. et al. Polyploid giant cancer cells: Unrecognized actuators of tumorigenesis, metastasis, and resistance. Prostate 79(13), 1489–1497 (2019).
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献